Page last updated: 2024-11-06

floxuridine and Leukemia, T-Cell

floxuridine has been researched along with Leukemia, T-Cell in 1 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wagner, CR1
Ballato, G1
Akanni, AO1
McIntee, EJ1
Larson, RS1
Chang, S1
Abul-Hajj, YJ1

Other Studies

1 other study available for floxuridine and Leukemia, T-Cell

ArticleYear
Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors.
    Cancer research, 1997, Jun-15, Volume: 57, Issue:12

    Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Division; Dose-Response Relationshi

1997